IGF-1 c.258 A > G synonymous mutation ameliorates senile osteoporosis

Abstract Senile osteoporosis (SOP) is a multifactorial, age-related progressive phenomenon with a considerable morbidity and mortality. IGF-1 is an important regulator of bone reconstruction and metabolism throughout life. Nevertheless, our previous study unexpectedly found there is no change in the...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhaoguo Wang, Dayou Dai, Siyao Wang, Libo Zhang, Yi Li, Xunming Zhang, Yunyun Cheng, Linlin Hao
Format: Article
Language:English
Published: Nature Portfolio 2024-12-01
Series:Communications Biology
Online Access:https://doi.org/10.1038/s42003-024-07369-x
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850102687744393216
author Zhaoguo Wang
Dayou Dai
Siyao Wang
Libo Zhang
Yi Li
Xunming Zhang
Yunyun Cheng
Linlin Hao
author_facet Zhaoguo Wang
Dayou Dai
Siyao Wang
Libo Zhang
Yi Li
Xunming Zhang
Yunyun Cheng
Linlin Hao
author_sort Zhaoguo Wang
collection DOAJ
description Abstract Senile osteoporosis (SOP) is a multifactorial, age-related progressive phenomenon with a considerable morbidity and mortality. IGF-1 is an important regulator of bone reconstruction and metabolism throughout life. Nevertheless, our previous study unexpectedly found there is no change in the peak bone mass with a altered IGF-1 gene expression leaded by IGF-1 c.258 A > G synonymous mutation. Considering its involvement in the cellular senescence, we suspected c.258 A > G may participate in SOP. Therefore, the effect of IGF-1 c.258 A > G on SOP was firstly detected, the changes of bone formation and bone resorption index in SOP mice with two genotypes indicated it improved SOP. Then, the in vitro study confirmed the mutation ameliorates SOP by promoting the growth and development of senescent osteoblasts. At last, co-culture of osteoblast and osteoclast further verified the mutation prevents SOP by increasing the bone formation capacity of senescent osteoblasts. Collectively, this study illuminated the role of IGF-1 c.258 A > G in ameliorating SOP.
format Article
id doaj-art-bd634e8d26994e07837e2b91639b9166
institution DOAJ
issn 2399-3642
language English
publishDate 2024-12-01
publisher Nature Portfolio
record_format Article
series Communications Biology
spelling doaj-art-bd634e8d26994e07837e2b91639b91662025-08-20T02:39:41ZengNature PortfolioCommunications Biology2399-36422024-12-017111110.1038/s42003-024-07369-xIGF-1 c.258 A > G synonymous mutation ameliorates senile osteoporosisZhaoguo Wang0Dayou Dai1Siyao Wang2Libo Zhang3Yi Li4Xunming Zhang5Yunyun Cheng6Linlin Hao7College of Animal Science, Jilin UniversityState Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Ren Ji Hospital, School of medicine, Shanghai Jiao Tong UniversityCollege of Animal Science, Jilin UniversityCollege of Animal Science, Jilin UniversityCollege of Animal Science, Jilin UniversityCollege of Animal Science, Jilin UniversityCollege of Animal Science, Jilin UniversityCollege of Animal Science, Jilin UniversityAbstract Senile osteoporosis (SOP) is a multifactorial, age-related progressive phenomenon with a considerable morbidity and mortality. IGF-1 is an important regulator of bone reconstruction and metabolism throughout life. Nevertheless, our previous study unexpectedly found there is no change in the peak bone mass with a altered IGF-1 gene expression leaded by IGF-1 c.258 A > G synonymous mutation. Considering its involvement in the cellular senescence, we suspected c.258 A > G may participate in SOP. Therefore, the effect of IGF-1 c.258 A > G on SOP was firstly detected, the changes of bone formation and bone resorption index in SOP mice with two genotypes indicated it improved SOP. Then, the in vitro study confirmed the mutation ameliorates SOP by promoting the growth and development of senescent osteoblasts. At last, co-culture of osteoblast and osteoclast further verified the mutation prevents SOP by increasing the bone formation capacity of senescent osteoblasts. Collectively, this study illuminated the role of IGF-1 c.258 A > G in ameliorating SOP.https://doi.org/10.1038/s42003-024-07369-x
spellingShingle Zhaoguo Wang
Dayou Dai
Siyao Wang
Libo Zhang
Yi Li
Xunming Zhang
Yunyun Cheng
Linlin Hao
IGF-1 c.258 A > G synonymous mutation ameliorates senile osteoporosis
Communications Biology
title IGF-1 c.258 A > G synonymous mutation ameliorates senile osteoporosis
title_full IGF-1 c.258 A > G synonymous mutation ameliorates senile osteoporosis
title_fullStr IGF-1 c.258 A > G synonymous mutation ameliorates senile osteoporosis
title_full_unstemmed IGF-1 c.258 A > G synonymous mutation ameliorates senile osteoporosis
title_short IGF-1 c.258 A > G synonymous mutation ameliorates senile osteoporosis
title_sort igf 1 c 258 a g synonymous mutation ameliorates senile osteoporosis
url https://doi.org/10.1038/s42003-024-07369-x
work_keys_str_mv AT zhaoguowang igf1c258agsynonymousmutationamelioratessenileosteoporosis
AT dayoudai igf1c258agsynonymousmutationamelioratessenileosteoporosis
AT siyaowang igf1c258agsynonymousmutationamelioratessenileosteoporosis
AT libozhang igf1c258agsynonymousmutationamelioratessenileosteoporosis
AT yili igf1c258agsynonymousmutationamelioratessenileosteoporosis
AT xunmingzhang igf1c258agsynonymousmutationamelioratessenileosteoporosis
AT yunyuncheng igf1c258agsynonymousmutationamelioratessenileosteoporosis
AT linlinhao igf1c258agsynonymousmutationamelioratessenileosteoporosis